brande yaist

senior director- center of expertise, global patient outcomes and real world evidence

About

Brande has breadth and depth of skills related to 6 Sigma, project management, and leadership/change management. She is able to leverage her strengths across a breadth of projects and activities and can effectively lead transformation. Her motivation to drive change and integrate a team to shared vision and related action plan is demonstrated in the growth and success of teams she leads. She adds creative problem solving to team dynamics, and is a self-starter that is able to motivate others. Brande is dependable and reliable, assuming accountability for results. Brande is identified as a leader among reports, peers, and business partners. She values people and quickly builds effective relationships. Brande stresses the importance of proactive thinking, implementing risk-taking behaviors, and evaluating situations and implications of actions taken. Specialties: Lean Six Sigma, Change Management, Real World Evidence, Pharmacovigilance and Risk Minimization, Supervision, Project Management, Clinical Development, Oncology, Neuroscience

Country

united states

City

indianapolis

Industry

pharmaceuticals

Skill

clinical trials, clinical development, oncology, pharmaceutical industry, clinical research, six sigma, pharmacovigilance, neuroscience, change management, medical education, commercialization, osteoporosis, team building, time management

Experience

director- real world evidence hub

eli lilly and company

2013-9 - Present · 13 yrs 1 mo

Leading a cross-functional hub hosted by Global Patient Outcomes & Real World Evidence (GPORWE) in collaboration with Statistics, Data Sciences, Patient Safety, and IT to enable enterprise-wide coordination and transformation of Real World Evidence (RWE) data strategy, infrastructure & partnerships. Responsible for leading the group in the development of innovative RWE related capabilities as well as enable efficient execution of in-house RWE studies through internal Real World Data (RWD) assets.

advisor- office of risk management and pharmacoepidemiology

eli lilly and company

2010-3 - Present · 16 yrs 7 mos

Oversee the development and management of business processes related to risk minimization. Contribute to the continuing development of standards, procedures and tools to facilitate the design, assessment and monitoring of risk minimization plans (RMiPs), as well as contribute to the overall risk management strategy. Act as the integrator of the risk minimization process with other functions, business processes and geographies.

six sigma black belt

eli lilly and company

2008-2 - 2010-3 · 2 yrs 2 mos

Lead DMAIC and Design for Lean Six Sigma projects for LRL. Project Management for MQS Redesign Disclose Workstream.

clinical supervisor

eli lilly and company

2003-6 - 2008-2 · 4 yrs 9 mos

Plan and oversee clinical development for NS compounds marketed in the US. Supervise consultants, associates, and assistance in clinical trial planning and execution, as well as medical writers and editors in early phase clinical research.

clinical project associate

eli lilly and company

2001-9 - 2003-6 · 1 yr 10 mos

Coordination and oversight of early phase oncology clinical trials.

clinical research administrator

eli lilly and company

2000-8 - 2001-9 · 1 yr 2 mos

Clinical Research Monitor for Oncology Trials. Responsibilities include source data verification, drug accountability, and verification of regulatory requirements.

clinical research administrator

washington university in st. louis

1998-2 - 2000-8 · 2 yrs 7 mos

Coordinate phase 1 oncology clinical trials, including data collection, protocol adherence, and patient follow-up. Provided database support for investigator initiated trials.

accounts receivable

ronnoco coffee company

1994-1 - 1998-1 · 4 yrs 1 mo

senior director- center of expertise, global patient outcomes and real world evidence

eli lilly and company

2014-7 - Present · 12 yrs 3 mos

* Lead and developresearch talent and capabilities needed to provide scientific services/expertise across an array of core Health Economics & Outcomes Research (HEOR) capabilities which are divided into four units: * Real World Evidence hub (RWE, Inc.) , * Patient Focused Outcomes Unit * Early-Phase Support Unit, and * the GPORWE policy hub